The proteomic and particle composition of human platelet lysate for cell therapy products
- 26 July 2022
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 123 (9) , 1495-1505
Abstract
Following health agencies warning, the use of animal origin supplements should be avoided in biological products proposed as therapy in humans. Platelet lysate and several other growth factors sources are alternatives to replace fetal calf serum, the current gold standard in clinical‐grade cell culture. However, the platelet supplement's content lacks data due to different production methods. The principle behind these products relays on the lysis of platelets that release several proteins, some of which are contained in heterogeneous granules and coordinate biological functions. This study aims to analyze the composition and reproducibility of a platelet lysate produced with a standardized method, by describing several batches' protein and particle content using proteomics and dynamic light scattering. Proteomics data revealed a diversified protein content, with some related to essential cellular processes such as proliferation, morphogenesis, differentiation, biosynthesis, adhesion, and metabolism. It also detected proteins responsible for activation and binding of transforming growth factor beta, hepatocyte growth factor, and insulin‐like growth factor. Total protein, biochemical, and growth factors quantitative data showed consistent and reproducible values across batches. Novel data on two major particle populations is presented, with high dispersion level at 231 ± 96 d.nm and at 30 ± 8 d.nm, possibly being an important way of protein trafficking through the cellular microenvironment. This experimental and descriptive analysis aims to support the content definition and quality criteria of a cell supplement for clinical applications.Keywords
Funding Information
- Financiadora de Estudos e Projetos (01.08.0630.01)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (23038.004681/2014‐67)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (404896/2012‐0, 443907/2018‐8)
This publication has 53 references indexed in Scilit:
- Platelet Lysates Produced from Expired Platelet Concentrates Support Growth and Osteogenic Differentiation of Mesenchymal Stem CellsPLOS ONE, 2013
- Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factorsStem Cell Research & Therapy, 2013
- Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active componentsCytotherapy, 2012
- Detection and Identification of the Atypical Bovine Pestiviruses in Commercial Foetal Bovine Serum BatchesPLOS ONE, 2011
- Platelet Lysate Consisting of a Natural Repair Proteome Supports Human Mesenchymal Stem Cell Proliferation and Chromosomal StabilityCell Transplantation, 2011
- Optimization of chemically defined cell culture media – Replacing fetal bovine serum in mammalian in vitro methodsToxicology in Vitro, 2010
- High-throughput functional annotation and data mining with the Blast2GO suiteNucleic Acids Research, 2008
- Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applicationsJournal of Cellular Physiology, 2005
- GENETICS OF SOMATIC MAMMALIAN CELLSJournal of Experimental Medicine, 1958
- Chemical Composition of Blood Plasma and SerumAnnual Review of Biochemistry, 1950